ES8305003A1 - "procedimiento para la preparacion de derivados de androstano". - Google Patents

"procedimiento para la preparacion de derivados de androstano".

Info

Publication number
ES8305003A1
ES8305003A1 ES514492A ES514492A ES8305003A1 ES 8305003 A1 ES8305003 A1 ES 8305003A1 ES 514492 A ES514492 A ES 514492A ES 514492 A ES514492 A ES 514492A ES 8305003 A1 ES8305003 A1 ES 8305003A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
androstane derivatives
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES514492A
Other languages
English (en)
Spanish (es)
Other versions
ES514492A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES514492A0 publication Critical patent/ES514492A0/es
Publication of ES8305003A1 publication Critical patent/ES8305003A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES514492A 1981-07-29 1982-07-29 "procedimiento para la preparacion de derivados de androstano". Expired ES8305003A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813130644 DE3130644A1 (de) 1981-07-29 1981-07-29 Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten

Publications (2)

Publication Number Publication Date
ES514492A0 ES514492A0 (es) 1983-04-16
ES8305003A1 true ES8305003A1 (es) 1983-04-16

Family

ID=6138450

Family Applications (1)

Application Number Title Priority Date Filing Date
ES514492A Expired ES8305003A1 (es) 1981-07-29 1982-07-29 "procedimiento para la preparacion de derivados de androstano".

Country Status (17)

Country Link
US (2) US4457925A (en, 2012)
EP (1) EP0071153B1 (en, 2012)
JP (1) JPS5849400A (en, 2012)
AT (1) ATE22086T1 (en, 2012)
AU (1) AU558412B2 (en, 2012)
CA (1) CA1210754A (en, 2012)
DE (2) DE3130644A1 (en, 2012)
DK (1) DK164325B (en, 2012)
ES (1) ES8305003A1 (en, 2012)
FI (1) FI78110C (en, 2012)
GB (1) GB2104899B (en, 2012)
GR (1) GR76872B (en, 2012)
IE (1) IE53711B1 (en, 2012)
IL (1) IL66311A (en, 2012)
NO (1) NO159661C (en, 2012)
PT (1) PT75334B (en, 2012)
ZA (1) ZA825480B (en, 2012)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331824A1 (de) * 1983-09-01 1985-03-21 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 17(alpha)-acyloxy-6-chlor-1(alpha),2(alpha)-methylen-3,20-dionen
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JPS61286185A (ja) * 1985-06-13 1986-12-16 Yoshizo Koishi 刻印装置
DE3824247A1 (de) * 1988-07-13 1990-01-18 Schering Ag Neue androstan-derivate
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
DE4102244A1 (de) * 1991-01-24 1992-07-30 Schering Ag 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US20040242618A1 (en) * 2003-04-01 2004-12-02 Lardy Henry A. Antiandrogens with marginal agonist activity and methods of use
US8084446B2 (en) 2005-04-26 2011-12-27 Eric Marchewitz Use of DHEA derivatives for enhancing physical performance
US20130123523A1 (en) * 2011-11-10 2013-05-16 Klaus Nickisch Methods for the preparation of etonogestrel and desogestrel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7871M (en, 2012) * 1968-11-13 1970-04-27
DE2644427A1 (de) * 1976-09-30 1978-04-06 Schering Ag 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
DE2722706A1 (de) * 1977-05-16 1978-12-07 Schering Ag 15.16-methylen-androsta-4.15-dien- 3-one und verfahren zu ihrer herstellung
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.

Also Published As

Publication number Publication date
IE53711B1 (en) 1989-01-18
IL66311A (en) 1986-03-31
NO159661B (no) 1988-10-17
PT75334B (de) 1984-07-31
GB2104899B (en) 1985-01-30
AU558412B2 (en) 1987-01-29
ZA825480B (en) 1983-11-30
US4587235A (en) 1986-05-06
PT75334A (de) 1982-08-01
FI822658L (fi) 1983-01-30
ATE22086T1 (de) 1986-09-15
ES514492A0 (es) 1983-04-16
GB2104899A (en) 1983-03-16
EP0071153A1 (de) 1983-02-09
DK164325B (da) 1992-06-09
DE3273186D1 (en) 1986-10-16
DK327082A (da) 1983-01-30
NO159661C (no) 1989-01-25
AU8643982A (en) 1984-10-18
FI78110C (fi) 1989-06-12
DE3130644A1 (de) 1983-02-17
IL66311A0 (en) 1982-11-30
CA1210754A (en) 1986-09-02
NO822596L (no) 1983-01-31
JPH033678B2 (en, 2012) 1991-01-21
JPS5849400A (ja) 1983-03-23
US4457925A (en) 1984-07-03
EP0071153B1 (de) 1986-09-10
FI822658A0 (fi) 1982-07-29
FI78110B (fi) 1989-02-28
IE821824L (en) 1983-01-29
GR76872B (en, 2012) 1984-09-04

Similar Documents

Publication Publication Date Title
DE3367774D1 (de) 5,6,7-trinor-4, 8-inter-m-phenylene prostaglandin i2 derivatives
ES8305003A1 (es) "procedimiento para la preparacion de derivados de androstano".
GB1536515A (en) Compositions containing silicon derivatives
IL57691A0 (en) New 3,20-dioxo-4,9-diene-21-hydroxyl steroid derivatives,process for preparing them and their use as medicaments and the pharmaceutical compositions containing them
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
DE3266845D1 (en) Hydrocortisone derivatives, their preparation and their utilization
ZA836090B (en) Thieno-thiazole derivatives,processes for preparing these compounds,and pharmaceutical compositions thereof
IE41767L (en) Dihydroergopeptine derivatives
DE3261515D1 (en) Benzopyranyl ethers, process for their preparation and medicine containing those compounds and intermediates
EP0520879A3 (en, 2012)
DE3160968D1 (en) Cardenolide-bis-digitoxoside derivatives, process for their preparation and their utilization as medicines
US4264523A (en) 19,20-Didehydro-13,14-dihydro-PG1 amides
US4278813A (en) 19,20-Didehydro-13,14-dihydro-PG2, sulfonyl amides
US4278812A (en) 19,20-Didehydro-PG2 sulfonyl amides
US4283351A (en) 19,20-Didehydro-13,14-dihydro-PG2 amides
US4257983A (en) 2-Decarboxy-2-aminomethyl-19,20-didehydro-PG1 compounds
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519